The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Phosphocholine as a biomarker of breast cancer: Molecular and biochemical studies
Open accessAbstract
The discovery of metabolic and molecular markers that help improving the detection and diagnosis of breast cancer is an important goal to be achieved. A high composite‐choline signal in magnetic resonance spectra of breast lesions has been demonstrated to improve the accuracy of breast cancer diagnosis. In the present study we revealed the principal molecular and biochemical steps associated with the induction of choline metabolism and phosphocholine accumulation in human breast cancer cell‐lines in comparison with normal human mammary epithelial cells. We found upregulation of the expression levels of specific choline transporters: organic cation transporter‐2 and choline high affinity transporter‐1, as well as of the enzyme choline kinase α in the cancerous cells in comparison with that in the normal mammary epithelial cells. The expression levels of choline transporter like‐1, organic cation transporter‐1 and choline kinase β were similar in normal and cancerous cells. We further showed that choline transport rates and choline kinase activity indeed increased by several fold in the cancer cells leading to the elevation of phosphocholine. The results strongly suggest that phosphocholine can serve as a biomarker of breast cancer reflecting upregulation of specific choline transporters and choline kinase genes. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
MR Imaging of the Breast for the Detection, Diagnosis, and Staging of Breast Cancer
Orel, S. G., & Schnall, M. D. (2001) · Radiology · doi:10.1148/radiology.220.1.r01jl3113 · Cited by 759
Studies of human tumors by MRS: A review
Negendank, W. (1992) · NMR in Biomedicine · doi:10.1002/nbm.1940050518 · Cited by 660
Choline, an essential nutrient for humans
Zeisel, S. H., Da Costa, K., Franklin, P. D., Alexander, E. A., Lamont, J. T., Sheard, N. F., & Beiser, A. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.7.2010061 · Cited by 622
Global trends in breast cancer incidence and mortality 1973–1997
Althuis, M. D., Dozier, J. M., Anderson, W. F., Devesa, S. S., & Brinton, L. A. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyh414 · Cited by 564
Aboagye, E. O., & Bhujwalla, Z. M. (1999) · PubMed · Cited by 546
The SLC22 drug transporter family
Koepsell, H., & Endou, H. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1089-9 · Cited by 525
Thompson, E. W., Paik, S., Brünner, N., Sommers, C. L., Zugmaier, G., Clarke, R., Shima, T. B., Torri, J., Donahue, S., Lippman, M. E., et al. (1992) · Journal of Cellular Physiology · doi:10.1002/jcp.1041500314 · Cited by 523
Blusztajn, J. K. (1998) · Science · doi:10.1126/science.281.5378.794 · Cited by 408
Molecular Causes of the Aberrant Choline Phospholipid Metabolism in Breast Cancer
Glunde, K., Jie, C., & Bhujwalla, Z. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3829 · Cited by 380
Phospholipid biosynthesis in mammalian cells
Vance, J. E., & Vance, D. E. (2004) · Biochemistry and Cell Biology · doi:10.1139/o03-073 · Cited by 373
Ramı́rez de Molina, A., Rodrı́guez-González, A., Gutiérrez, R., Martı́nez-Piñeiro, L., Sánchez, J. J., Bonilla, F., Rosell, R., & Lacal, J. C. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00920-8 · Cited by 340
Koepsell, H., Schmitt, B. M., & Gorboulev, V. (2003) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/s10254-003-0017-x · Cited by 316
Alterations of Choline Phospholipid Metabolism in Ovarian Tumor Progression
Iorio, E., Mezzanzanica, D., Alberti, P., Spadaro, F., Ramoni, C., D'Ascenzo, S., Millimaggi, D., Pavan, A., Dolo, V., Canevari, S., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1146 · Cited by 309
Multistep carcinogenesis of breast cancer and tumour heterogeneity
Beckmann, M. W., Niederacher, D., Schnürch, H.-G., Gusterson, B. A., & Bender, H. G. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050128 · Cited by 299
Phospholipase D in cell proliferation and cancer.
Foster, D. A., & Xu, L. (2003) · PubMed · Cited by 298
A Novel Method for Measurement of Submembrane ATP Concentration
Gribble, F. M., Loussouarn, G., Tucker, S. J., Zhao, C., Nichols, C. G., & Ashcroft, F. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001010200 · Cited by 279
Clinical Utility of Proton Magnetic Resonance Spectroscopy in Characterizing Breast Lesions
Katz-Brull, R. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.16.1197 · Cited by 267
Ramírez de Molina, A., Gutiérrez, R., Ramos, M. A., Silva, J. M., Silva, J., Bonilla, F., Sánchez, J. J., & Lacal, J. C. (2002) · Oncogene · doi:10.1038/sj.onc.1205556 · Cited by 257
Katz‐Brull, R., Seger, D., Rivenzon‐Segal, D., Rushkin, E., & Degani, H. (2002) · PubMed · Cited by 221
Self-citationStructure and function of choline kinase isoforms in mammalian cells
Aoyama, C., Liao, H., & Ishidate, K. (2004) · Progress in Lipid Research · doi:10.1016/j.plipres.2003.12.001 · Cited by 213
Lockman, P. R., & Allen, D. D. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120005622 · Cited by 174
Katz‐Brull, R., & Degani, H. (1996) · PubMed · Cited by 169
Self-citationPhosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors.
Cuadrado, A., Carnero, A., Dolfi, F., Jiménez, B., & Lacal, J. C. (1993) · PubMed · Cited by 165
FDG-PET and Beyond: Molecular Breast Cancer Imaging
Quon, A., & Gambhir, S. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.024 · Cited by 159
Meisamy, S., Bolan, P. J., Baker, E. H., Pollema, M. G., Le, C. T., Kelcz, F., Lechner, M. C., Luikens, B. A., Carlson, R. A., Brandt, K. R., et al. (2005) · Radiology · doi:10.1148/radiol.2362040836 · Cited by 142
Tyagi, R. K., Azrad, A., Degani, H., et al. (1996) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910350210 · Cited by 141
Self-citationde Molina, A. R., Báñez-Coronel, M., Gutiérrez, R., Rodrı́guez-González, A., Olmeda, D., Megı́as, D., & Lacal, J. C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0489 · Cited by 129
Normal plasma choline responses to ingested lecithin
Zeisel, S. H., Growdon, J. H., Wurtman, R. J., Magil, S. G., & Logue, M. P. (1980) · Neurology · doi:10.1212/wnl.30.11.1226 · Cited by 124
Regulatory enzymes of phosphatidylcholine biosynthesis: a personal perspective
Kent, C. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.12.008 · Cited by 120
Hernández-Alcoceba, R., Fernández, F., & Lacal, J. C. (1999) · PubMed · Cited by 118
High-Affinity Choline Transporter
Okuda, T., & Haga, T. (2003) · Neurochemical Research · doi:10.1023/a:1022809003997 · Cited by 105
Traiffort, É., Ruat, M., O'Regan, S., & Meunier, F.-M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02962.x · Cited by 101
A novel class of microbial phosphocholine‐specific phospholipases C
Stonehouse, M. J., Cota‐Gomez, A., Parker, S. K., Martin, W. E., Hankin, J. A., Murphy, R. C., Chen, W., Lim, K. B., Hackett, M., Vasil, A. I., et al. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03194.x · Cited by 100
Eukaryotic lipid-biosynthetic enzymes: the same but not the same
Vance, J. E. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01297-3 · Cited by 93
Jiménez, B., del Peso, L., Montaner, S., Esteve, P., & Lacal, J. C. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240570114 · Cited by 92
Inazu, M., Takeda, H., & Matsumiya, T. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03299.x · Cited by 91
Choline Kinase Is a Novel Oncogene that Potentiates RhoA-Induced Carcinogenesis
de Molina, A. R., Gallego‐Ortega, D., Sarmentero, J., Báñez-Coronel, M., Martín-Cantalejo, Y., & Lacal, J. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4416 · Cited by 87
Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells
Rodrı́guez-González, A., de Molina, A. R., Fernández, F., Ramos, M. A., Núñez, M. D. C., Rosa, J. M. C., & Lacal, J. C. (2003) · Oncogene · doi:10.1038/sj.onc.1207062 · Cited by 84
Bodennec, J., Pelled, D., Riebeling, C., Trajkovic, S., & Futerman, A. H. (2002) · The FASEB Journal · doi:10.1096/fj.02-0149fje · Cited by 79
Phosphatidylcholine-specific phospholipase C in mitogen-stimulated fibroblasts
Ramoni, C., Spadaro, F., Barletta, B., Dupuis, M. L., & Podo, F. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.05.037 · Cited by 72
Mammography and breast cancer: the new era
Tabár, L. K., & Dean, P. B. (2003) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(03)00262-5 · Cited by 63
Savendahl, L. S., Mar, M., Underwood, L., et al. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/66.3.622 · Cited by 58
Ramoni, C., Spadaro, F., Menegon, M., & Podo, F. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2642 · Cited by 54
Ronen, S. M., Rushkin, E., & Degani, H. (1991) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(91)90038-y · Cited by 54
Self-citationGlycerophosphocholine and Phosphocholine Are the Major Choline Metabolites in Rat Milk
Rohlfs, E. M., Garner, S. C., Mar, M.-H. H., & Zeisel, S. H. (1993) · Journal of Nutrition · doi:10.1093/jn/123.10.1762 · Cited by 51
Fullerton, M. D., Wagner, L., Yuan, Z., & Bakovic, M. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00255.2005 · Cited by 47
Ronen, S. M., Rushkin, E., & Degani, H. (1992) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(92)90039-p · Cited by 42
Self-citationCholine Uptake in Human Intestinal Caco-2 Cells Is Carrier-Mediated
Kamath, A. V., Darling, I. M., & Morris, M. E. (2003) · Journal of Nutrition · doi:10.1093/jn/133.8.2607 · Cited by 41
Rivenzon‐Segal, D., Rushkin, E., Polak‐Charcon, S., & Degani, H. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.3.e508 · Cited by 40
Self-citationLacal, J. C. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)80913-7 · Cited by 37
From Ras signalling to ChoK inhibitors: a further advance in anticancer drug design
de Molina, A. R. (2003) · Cancer Letters · doi:10.1016/j.canlet.2003.08.031 · Cited by 37
Momchilova, A., & Markovska, T. T. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(98)00111-3 · Cited by 28
Yamazaki, N., Shinohara, Y., Kajimoto, K., Shindo, M., & Terada, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006322200 · Cited by 20
Cited by
The Kennedy pathway—De novo synthesis of phosphatidylethanolamine and phosphatidylcholine
Gibellini, F., & Smith, T. K. (2010) · IUBMB Life · doi:10.1002/iub.337 · Cited by 830
Choline metabolism in malignant transformation
Glunde, K., Bhujwalla, Z. M., & Ronen, S. M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3162 · Cited by 823
Breast cancer diagnosis: Imaging techniques and biochemical markers
Jafari, S. H., Saadatpour, Z., Salmaninejad, A., Momeni, F., Mokhtari, M., Nahand, J. S., Rahmati, M., Mirzaei, H., & Kianmehr, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26379 · Cited by 410
Serum metabolomics for early diagnosis of esophageal squamous cell carcinoma by UHPLC-QTOF/MS
Wang, J., Zhang, T., Shen, X., Liu, J., Zhao, D., Sun, Y., Wang, L., Liu, Y., Gong, X., Liu, Y., et al. (2016) · Metabolomics · doi:10.1007/s11306-016-1050-5 · Cited by 373
The role of phosphatidylcholine and choline metabolites to cell proliferation and survival
Ridgway, N. D. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2012.735643 · Cited by 339
Metadata
- Authors
- Eliyahu, G., Kreizman, T., & Degani, H.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2007-02-21
- Volume
- 120
- Issue
- 8
- Pages
- 1721-1730
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2020058751
- Cited by
- 252
- References
- 54
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.